OUR BLOG

On May 12, 2026, a global panel officially renamed polycystic ovary syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This shift updates a misleading title to accurately reflect a systemic, lifelong hormonal and metabolic disorder. For the hypermobility and neurodivergent communities, this landmark decision validates a shared history of diagnostic delays and highlights the urgent need to look past isolated symptoms toward whole-body healthcare.

Emerging research is revealing significant links between bipolar disorder, neurodivergence, and hypermobility. For many people, mood shifts, emotional dysregulation, sensory overwhelm, and exhaustion may be more connected to chronic pain, nervous-system stress, and connective tissue dysfunction than previously understood. This article explores the science behind these overlaps and why medicine may need a more integrated approach to body and mind.

Migraine is more than a headache. It is a neurological condition that affects sensory processing, energy regulation, and daily functioning. It is also more common in people with hypermobility, ADHD, and autism. This article explains why migraine occurs more frequently in this population, how triggers such as sleep, hydration, and blood sugar play a role, and what approaches, including lifestyle and medical treatment, can help reduce frequency and severity.

Chronic abdominal pain in hypermobility is often dismissed or misunderstood. Median Arcuate Ligament Syndrome (MALS) is a lesser-known condition that may explain severe, persistent symptoms, especially when tests come back normal. This article explores how MALS works, why it can be missed, and what patterns may help you recognize when something more specific is going on in your body.